Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Microfibrillar-Associated Protein 4: A Potential Biomarker for Screening for Liver Fibrosis in a Mixed Patient Cohort

13 Oct 2015

Abstract excerpt

BACKGROUND AND AIMS: A method for assessment of liver fibrosis and cirrhosis without the need for a liver biopsy is desirable. Microfibrillar-associated protein 4 (MFAP4) is a suggested biomarker for identification of high-risk patients with severe fibrosis stages. This study aimed to examine associations between plasma MFAP4 (pMFAP4) and transient elastography or chronic hepatitis C virus infection in drug users...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Connective tissue disorders research
Share to Liver Disease Diagnosis and Treatment
Share to Liver physiology and pathology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26460565
DOI: 10.1371/journal.pone.0140418

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Microfibrillar-Associated Protein 4: A Potential Biomarker for Screening for Liver Fibrosis in a Mixed Patient CohortPMID 26460565Read ↗

Prediction of liver fibrosis severity in alcoholic liver disease by human microfibrillar‐associated protein 4Semantic proximity Read ↗

Enzyme-Linked Immunosorbent Assay Characterization of Basal Variation and Heritability of Systemic Microfibrillar-Associated Protein 4Semantic proximity Read ↗

Demarcating the Development of Cirrhosis and Its Complications via Plasma Proteomic Features in an Asymptomatic PopulationSemantic proximity Read ↗

FIB-4 First in Diagnostic Algorithm of MAFLD at the Era of “Global Metabodemic “Semantic proximity Read ↗

Real life application of FIB-4 & APRI during mass treatment of HCV genotype 4 with directly acting anti-viral agents in Egyptian patients, an observational study.Semantic proximity Read ↗

Affinity proteomics-based non-invasive detection of clinically significant liver diseaseSemantic proximity Read ↗

Evaluation of non-invasive markers of liver fibrosis in chronic hepatitis B patients in a sub- saharan African setting: Transient elastography Versus APRI, FIB4, GTT/ Platelet scoresSemantic proximity Read ↗

A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-significant and significant fibrosis in patients with chronic hepatitis C.Semantic proximity Read ↗

Alpha-1 Antitrypsin Deficiency in Patients With Cirrhosis in a US National Cohort.Semantic proximity Read ↗

Distinct metabolomic and lipidomic profiles associated with cirrhosis after HCV cure in people with HIV: findings at one and five yearsSemantic proximity Read ↗

Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis.Semantic proximity Read ↗

Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.